Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP870940.RAw1-pb8_9GI1AkakCEv0DZ-hcbYolk1g0D0BZTHZu_kQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP870940.RAw1-pb8_9GI1AkakCEv0DZ-hcbYolk1g0D0BZTHZu_kQ130_assertion type Assertion NP870940.RAw1-pb8_9GI1AkakCEv0DZ-hcbYolk1g0D0BZTHZu_kQ130_head.
- NP870940.RAw1-pb8_9GI1AkakCEv0DZ-hcbYolk1g0D0BZTHZu_kQ130_assertion description "[These results suggest that CD123 CAR T cells are a promising immunotherapy for the treatment of high-risk AML.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP870940.RAw1-pb8_9GI1AkakCEv0DZ-hcbYolk1g0D0BZTHZu_kQ130_provenance.
- NP870940.RAw1-pb8_9GI1AkakCEv0DZ-hcbYolk1g0D0BZTHZu_kQ130_assertion evidence source_evidence_literature NP870940.RAw1-pb8_9GI1AkakCEv0DZ-hcbYolk1g0D0BZTHZu_kQ130_provenance.
- NP870940.RAw1-pb8_9GI1AkakCEv0DZ-hcbYolk1g0D0BZTHZu_kQ130_assertion SIO_000772 24030378 NP870940.RAw1-pb8_9GI1AkakCEv0DZ-hcbYolk1g0D0BZTHZu_kQ130_provenance.
- NP870940.RAw1-pb8_9GI1AkakCEv0DZ-hcbYolk1g0D0BZTHZu_kQ130_assertion wasDerivedFrom befree-20140225 NP870940.RAw1-pb8_9GI1AkakCEv0DZ-hcbYolk1g0D0BZTHZu_kQ130_provenance.
- NP870940.RAw1-pb8_9GI1AkakCEv0DZ-hcbYolk1g0D0BZTHZu_kQ130_assertion wasGeneratedBy ECO_0000203 NP870940.RAw1-pb8_9GI1AkakCEv0DZ-hcbYolk1g0D0BZTHZu_kQ130_provenance.